| http://www.w3.org/ns/prov#value | - News BreaksJuly 9, 201416:02 EDTOCRXOcera Therapeutics files to sell common stock, no amount givenOcera intends to use the net proceeds from the proposed offering to continue to progress the clinical development of OCR-002 and for working capital and other general corporate purposes.
|
